Dyne Therapeutics Inc.

8.65+0.7100+8.94%Vol 569.18K1Y Perf -37.08%
Oct 3rd, 2023 16:00 DELAYED
BID8.29 ASK9.03
Open7.75 Previous Close7.94
Pre-Market- After-Market8.65
 - -  - -%
Target Price
25.00 
Analyst Rating
Strong Buy 1.00
Potential %
189.02 
Finscreener Ranking
★★★★+     54.73
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
★★★+     53.40
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★★★+     54.26
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
10.55 
Earnings Rating
Sell
Market Cap527.83M 
Earnings Date
2nd Nov 2023
Alpha0.00 Standard Deviation0.20
Beta0.16 

Today's Price Range

7.758.69

52W Range

7.8315.60

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-11.88%
1 Month
-32.54%
3 Months
-29.23%
6 Months
-28.14%
1 Year
-37.08%
3 Years
-58.32%
5 Years
-38.02%
10 Years
-58.06%

TickerPriceChg.Chg.%
DYN8.650.71008.94
AAPL172.40-1.3500-0.78
GOOG133.30-1.8700-1.38
MSFT313.39-8.4100-2.61
XOM115.830.20000.17
WFC38.67-0.9400-2.37
JNJ155.340.19000.12
FB196.640.99000.51
GE107.76-1.0300-0.95
JPM142.71-1.0600-0.74
Financial StrengthValueIndustryS&P 500US Markets
10.60
11.10
0.10
0.12
-1 556.50
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
39.40
1.60
18.60
-23.60
-14.58
RevenueValueIndustryS&P 500US Markets
0.00
0.00
25.32
36.24
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.81-1.08-33.33
Q01 2023-0.77-0.78-1.30
Q04 2022-0.84-0.7411.90
Q03 2022-0.95-0.8015.79
Q02 2022-0.79-1.01-27.85
Q01 2022-0.88-0.6921.59
Q04 2021-0.99-1.00-1.01
Q03 2021-0.65-0.83-27.69
Earnings Per EndEstimateRevision %Trend
9/2023 QR-0.85-2.41Negative
12/2023 QR-0.783.70Positive
12/2023 FY-3.57-12.97Negative
12/2024 FY-3.183.34Positive
Next Report Date2nd Nov 2023
Estimated EPS Next Report-0.85
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume569.18K
Shares Outstanding61.02K
Shares Float40.95M
Trades Count6.35K
Dollar Volume4.75M
Avg. Volume506.18K
Avg. Weekly Volume517.07K
Avg. Monthly Volume587.88K
Avg. Quarterly Volume413.60K

Dyne Therapeutics Inc. (NYSE: DYN) stock closed at 7.94 per share at the end of the most recent trading day (a -11.38% change compared to the prior day closing price) with a volume of 469.80K shares and market capitalization of 527.82M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 36 people. Dyne Therapeutics Inc. CEO is Joshua T. Brumm.

The one-year performance of Dyne Therapeutics Inc. stock is -37.08%, while year-to-date (YTD) performance is -31.49%. DYN stock has a five-year performance of -38.02%. Its 52-week range is between 7.83 and 15.6, which gives DYN stock a 52-week price range ratio of 10.55%

Dyne Therapeutics Inc. currently has a PE ratio of -3.30, a price-to-book (PB) ratio of 2.43, a price-to-sale (PS) ratio of -, a price to cashflow ratio of 3.50, a PEG ratio of -, a ROA of -47.24%, a ROC of -50.15% and a ROE of -54.55%. The company’s profit margin is -14.58%, its EBITDA margin is 18.60%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Dyne Therapeutics Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.85 for the next earnings report. Dyne Therapeutics Inc.’s next earnings report date is 02nd Nov 2023.

The consensus rating of Wall Street analysts for Dyne Therapeutics Inc. is Strong Buy (1), with a target price of $25, which is +189.02% compared to the current price. The earnings rating for Dyne Therapeutics Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Dyne Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Dyne Therapeutics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 12.77, ATR14 : 0.69, CCI20 : -102.90, Chaikin Money Flow : 0.06, MACD : -0.68, Money Flow Index : 28.09, ROC : -14.99, RSI : 30.28, STOCH (14,3) : 4.93, STOCH RSI : 0.00, UO : 40.96, Williams %R : -95.07), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Dyne Therapeutics Inc. in the last 12-months were: Beskrovnaya Oxana (Sold 2 891 shares of value $37 209 ), Brumm Joshua T (Option Exercise at a value of $286 371), Brumm Joshua T (Sold 325 330 shares of value $4 195 796 ), Farwell Wildon (Sold 1 698 shares of value $21 106 ), HIGH SUSANNA GATTI (Sold 1 625 shares of value $20 199 ), Jason P. Rhodes (Buy at a value of $10 000 017), Jonathan Mcneill (Option Excercise at a value of $14 600), Jonathan McNeill (Sold 87 449 shares of value $1 070 283 ), Joshua Brumm (Sold 0 shares of value $-286 371 ), Joshua Brumm (Sold 332 648 shares of value $4 293 344 ), Joshua T. Brumm (Option Excercise at a value of $216 300), Joshua T. Brumm (Sold 220 640 shares of value $2 763 181 ), McNeill Jonathan (Sold 2 259 shares of value $28 649 ), Oxana Beskrovnaya (Sold 2 096 shares of value $26 267 ), Richard William Scalzo (Sold 0 shares of value $-41 200 ), Richard William Scalzo (Sold 54 324 shares of value $691 520 ), Susanna High (Sold 2 310 shares of value $28 945 ), Wildon Farwell (Sold 9 767 shares of value $127 121 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (100.00 %)
8 (100.00 %)
8 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

CEO: Joshua T. Brumm

Telephone: +1 781 786-8230

Address: 830 Winter Street, Waltham 02451, MA, US

Number of employees: 36

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

56%44%

Bearish Bullish

54%46%

 

News

Stocktwits